| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8529311 | European Journal of Pharmacology | 2018 | 37 Pages |
Abstract
Our findings suggest that continuous long-term application of appropriate CRAC inhibitors such as YM-58483 is a potential therapeutic strategy for global immunosuppression in RA.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Maya Miyoshi, Shuang Liu, Asuka Morizane, Erika Takemasa, Yashuyuki Suzuki, Takeshi Kiyoi, Kazutaka Maeyama, Masaki Mogi,